203 related articles for article (PubMed ID: 36106533)
1. Concentration and proteolysis of CX3CL1 may regulate the microglial response to CX3CL1.
Finneran D; Li Q; Subbarayan MS; Joly-Amado A; Kamath S; Dengler DG; Gordon MN; Jackson MR; Morgan D; Bickford PC; Smith LH; Nash KR
Glia; 2023 Feb; 71(2):245-258. PubMed ID: 36106533
[TBL] [Abstract][Full Text] [Related]
2. Fractalkine isoforms differentially regulate microglia-mediated inflammation and enhance visual function in the diabetic retina.
Rodriguez D; Church KA; Pietramale AN; Cardona SM; Vanegas D; Rorex C; Leary MC; Muzzio IA; Nash KR; Cardona AE
J Neuroinflammation; 2024 Feb; 21(1):42. PubMed ID: 38311721
[TBL] [Abstract][Full Text] [Related]
3. Modulation of inflammatory responses by fractalkine signaling in microglia.
Inoue K; Morimoto H; Ohgidani M; Ueki T
PLoS One; 2021; 16(5):e0252118. PubMed ID: 34019594
[TBL] [Abstract][Full Text] [Related]
4. FKN/CX3CR1 axis facilitates migraine-Like behaviour by activating thalamic-cortical network microglia in status epilepticus model rats.
Zhou Y; Zhang L; Hao Y; Yang L; Fan S; Xiao Z
J Headache Pain; 2022 Apr; 23(1):42. PubMed ID: 35382731
[TBL] [Abstract][Full Text] [Related]
5. CX3CL1 (Fractalkine)-CX3CR1 Axis in Inflammation-Induced Angiogenesis and Tumorigenesis.
Szukiewicz D
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38731899
[TBL] [Abstract][Full Text] [Related]
6. Fractalkine Enhances Hematoma Resolution and Improves Neurological Function via CX3CR1/AMPK/PPARγ Pathway After GMH.
Chen X; He X; Xu F; Xu N; Sharifi NH; Zhang P; Flores JJ; Wu L; He Q; Kanamaru H; Zhu S; Dong S; Han M; Yuan Y; Huang L; Miao L; Zhang JH; Zhou Y; Tang J
Stroke; 2023 Sep; 54(9):2420-2433. PubMed ID: 37465997
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective Effect of Fractalkine on Radiation-induced Brain Injury Through Promoting the M2 Polarization of Microglia.
Wang J; Pan H; Lin Z; Xiong C; Wei C; Li H; Tong F; Dong X
Mol Neurobiol; 2021 Mar; 58(3):1074-1087. PubMed ID: 33089423
[TBL] [Abstract][Full Text] [Related]
8. Up-regulated fractalkine (FKN) and its receptor CX3CR1 are involved in fructose-induced neuroinflammation: Suppression by curcumin.
Xu MX; Yu R; Shao LF; Zhang YX; Ge CX; Liu XM; Wu WY; Li JM; Kong LD
Brain Behav Immun; 2016 Nov; 58():69-81. PubMed ID: 26765996
[TBL] [Abstract][Full Text] [Related]
9. The liberation of fractalkine in the dorsal horn requires microglial cathepsin S.
Clark AK; Yip PK; Malcangio M
J Neurosci; 2009 May; 29(21):6945-54. PubMed ID: 19474321
[TBL] [Abstract][Full Text] [Related]
10. Microglia Mediate HIV-1 gp120-Induced Synaptic Degeneration in Spinal Pain Neural Circuits.
Ru W; Liu X; Bae C; Shi Y; Walikonis R; Mo Chung J; Tang SJ
J Neurosci; 2019 Oct; 39(42):8408-8421. PubMed ID: 31471472
[TBL] [Abstract][Full Text] [Related]
11. Ginsenoside Rg1 prevents vascular intimal hyperplasia involved by SDF-1α/CXCR4, SCF/c-kit and FKN/CX3CR1 axes in a rat balloon injury.
Hu A; Shuai Z; Liu J; Huang B; Luo Y; Deng J; Liu J; Yu L; Li L; Xu S
J Ethnopharmacol; 2020 Oct; 260():113046. PubMed ID: 32504784
[TBL] [Abstract][Full Text] [Related]
12. Pharmacological depletion of microglia alleviates neuronal and vascular damage in the diabetic CX3CR1-WT retina but not in CX3CR1-KO or hCX3CR1
Church KA; Rodriguez D; Mendiola AS; Vanegas D; Gutierrez IL; Tamayo I; Amadu A; Velazquez P; Cardona SM; Gyoneva S; Cotleur AC; Ransohoff RM; Kaur T; Cardona AE
Front Immunol; 2023; 14():1130735. PubMed ID: 37033925
[TBL] [Abstract][Full Text] [Related]
13. The Impact of the CX3CL1/CX3CR1 Axis in Neurological Disorders.
Pawelec P; Ziemka-Nalecz M; Sypecka J; Zalewska T
Cells; 2020 Oct; 9(10):. PubMed ID: 33065974
[TBL] [Abstract][Full Text] [Related]
14. Viral macrophage inflammatory protein-II and fractalkine (CX3CL1) chimeras identify molecular determinants of affinity, efficacy, and selectivity at CX3CR1.
Davis CN; Zujovic V; Harrison JK
Mol Pharmacol; 2004 Dec; 66(6):1431-9. PubMed ID: 15361546
[TBL] [Abstract][Full Text] [Related]
15. Integrins αvβ3 and α4β1 act as coreceptors for fractalkine, and the integrin-binding defective mutant of fractalkine is an antagonist of CX3CR1.
Fujita M; Takada YK; Takada Y
J Immunol; 2012 Dec; 189(12):5809-19. PubMed ID: 23125415
[TBL] [Abstract][Full Text] [Related]
16. The chemokine fractalkine can activate integrins without CX3CR1 through direct binding to a ligand-binding site distinct from the classical RGD-binding site.
Fujita M; Takada YK; Takada Y
PLoS One; 2014; 9(5):e96372. PubMed ID: 24789099
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the fractalkine chemokine domain. Basic amino acid residues differentially contribute to CX3CR1 binding, signaling, and cell adhesion.
Harrison JK; Fong AM; Swain PA; Chen S; Yu YR; Salafranca MN; Greenleaf WB; Imai T; Patel DD
J Biol Chem; 2001 Jun; 276(24):21632-41. PubMed ID: 11278650
[TBL] [Abstract][Full Text] [Related]
18. Fractalkine/CX3CR1-Dependent Modulation of Synaptic and Network Plasticity in Health and Disease.
Camacho-Hernández NP; Peña-Ortega F
Neural Plast; 2023; 2023():4637073. PubMed ID: 36644710
[TBL] [Abstract][Full Text] [Related]
19. Enhancing fractalkine/CX3CR1 signalling pathway can reduce neuroinflammation by attenuating microglia activation in experimental diabetic retinopathy.
Jiang M; Xie H; Zhang C; Wang T; Tian H; Lu L; Xu JY; Xu GT; Liu L; Zhang J
J Cell Mol Med; 2022 Feb; 26(4):1229-1244. PubMed ID: 35023309
[TBL] [Abstract][Full Text] [Related]
20. Two forms of CX3CL1 display differential activity and rescue cognitive deficits in CX3CL1 knockout mice.
Winter AN; Subbarayan MS; Grimmig B; Weesner JA; Moss L; Peters M; Weeber E; Nash K; Bickford PC
J Neuroinflammation; 2020 May; 17(1):157. PubMed ID: 32410624
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
